Carlyle Group Inc. SLNO Holdings History
Carlyle Group Inc.'s Soleno Therapeutics Inc Holding Summary
As of 2025-03-31, Carlyle Group Inc. held 860,980.00 shares of Soleno Therapeutics Inc(SLNO), totaling $61.45 Mil. This investment constitutes 1.62% of their stock portfolio, and Carlyle Group Inc. now holds 1.71% of the outstanding Soleno Therapeutics Inc(SLNO) stock.
The initial trade took place in 2023Q1. And since then Carlyle Group Inc. has made 4 purchases of SLNO, at an average price of $19.71, for a total of 4.07 Mil shares. In addition, there have been 2 sales at an average price of $51.34 for 3.21 Mil shares. Based on historical transaction data and SLNO's current price of $85.26, Carlyle Group Inc.'s estimated gain on his SLNO holdings is $157.99 Mil, reflecting a 196.84% gain to date.
Carlyle Group Inc. SLNO ($85.26) Holding Chart
Carlyle Group Inc. SLNO ($85.26) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
